• 7389 Citations
  • 40 h-Index
1987 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Christopher Bowlus is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Sclerosing Cholangitis Medicine & Life Sciences
Biliary Liver Cirrhosis Medicine & Life Sciences
Cholangitis Medicine & Life Sciences
Liver Medicine & Life Sciences
Ursodeoxycholic Acid Medicine & Life Sciences
Iron Medicine & Life Sciences
Liver Diseases Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1996 2016

Sclerosing Cholangitis
Acids
Bile Acids and Salts
Th17 Cells
Pharmacokinetics
Asian Americans
Liver Neoplasms
Hepatocellular Carcinoma
Hepatitis B virus
Survival Rate
Mutagenesis
Ascorbic Acid
Iron
Iron Overload
Hemochromatosis
Hemochromatosis
Organism Cloning
Yeast Artificial Chromosomes
Genes
Iron

Research Output 1987 2019

  • 7389 Citations
  • 40 h-Index
  • 126 Article
  • 10 Chapter
  • 7 Review article
  • 1 Short survey

Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry

Kuo, A., Gomel, R., Safer, R., Lindor, K. D., Everson, G. T. & Bowlus, C., Jun 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 7, p. 1372-1378 7 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Registries
Demography
Patient Reported Outcome Measures
Databases

Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancers

Mordaunt, C. E., Kieffer, D. A., Shibata, N. M., Członkowska, A., Litwin, T., Weiss, K. H., Zhu, Y., Bowlus, C., Sarkar, S., Cooper, S., Wan, Y-J. Y., Ali, M. R., LaSalle, J. M. & Medici, V., Jan 1 2019, In : Epigenetics and Chromatin. 12, 1, 0255.

Research output: Contribution to journalArticle

Hepatolenticular Degeneration
Hematologic Diseases
Epigenomics
Liver
Genome
1 Citation (Scopus)

Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study

Trauner, M., Nevens, F., Shiffman, M. L., Drenth, J. P. H., Bowlus, C., Vargas, V., Andreone, P., Hirschfield, G. M., Pencek, R., Malecha, E. S., MacConell, L. & Shapiro, D., Jun 1 2019, In : The Lancet Gastroenterology and Hepatology. 4, 6, p. 445-453 9 p.

Research output: Contribution to journalArticle

Cholangitis
Safety
Bilirubin
Ursodeoxycholic Acid
Alkaline Phosphatase
MicroRNAs
Colonic Neoplasms
Cells
Apoptosis
Histone Deacetylase Inhibitors
7 Citations (Scopus)

Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease

for the GS-US-321-0102 Investigators, Jan 1 2019, (Accepted/In press) In : Hepatology.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Protein-Lysine 6-Oxidase
Fibrosis
Placebos
Confidence Intervals